hrp0082p3-d1-668 | Bone | ESPE2014
Piona Claudia
, Moser Giovanni
, Ramaroli Diego
, Francesca Malesani
, Morandi Grazia
, Gaudino Rossella
, Antoniazzi Franco
Background: Cyclic treatment with bisphosphonates (BP) is now considered a standard care for children with osteogenesis imperfecta (OI). Vitamin D is a necessary nutrient for bone health for all children but especially for those with OI. In the literature few studies have considered the relationship between bone mineral density, vitamin D and pubertal stage in children treated with BP for OI.Objective and hypotheses: The purpose of this study...